Cenobamate significantly improves seizure control in intellectually disabled patients with drug-resistant epilepsy and allows drug load reduction

IntroductionEpilepsy patients with intellectual disability often suffer from drug-resistant epilepsy (DRE), which severely affects patients’ quality of life. Cenobamate (CNB) is a recently approved novel and effective ASM that can achieve high rates of seizure freedom in previously drug-resistant pa...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Anna-Lena Friedo, Benedikt Greshake, Konstantin L. Makridis, Hans-Beatus Straub
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2023-07-01
Ráidu:	Frontiers in Neurology
Fáttát:	cenobamate drug resistant epilepsy seizure freedom intellectual disability drug load anti-seizure medication
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1209487/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!